Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior

Proteomics

Volumn 8, Issue 16, 2008, Pages 3329-3341

  Yonezawa, Suguru ^a   Goto, Masamichi ^a   Yamada, Norishige ^a   Higashi, Michiyo ^a   Nomoto, Mitsuharu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Biological behavior; Human neoplasm; Malignancy potential; Mucin

Indexed keywords

HISTONE; MESSENGER RNA; MUCIN 1; MUCIN 2; MUCIN 4;

BEHAVIOR; BILE DUCT CANCER; BILE DUCT CARCINOMA; BREAST CARCINOMA; CANCER INVASION; DNA FLANKING REGION; DNA METHYLATION; EPIGENETICS; EXTRAHEPATIC BILE DUCT CARCINOMA; GENE CONTROL; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER CARCINOMA; LUNG ADENOCARCINOMA; NEOPLASM; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PAPILLOMA; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; STOMACH CARCINOMA; VATER PAPILLA CARCINOMA;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MUCIN-1; MUCIN-2; MUCIN-4; NEOPLASMS; PROGNOSIS; RNA, MESSENGER;

EID: 50449111478     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800040     Document Type: Review

References (69)

1. Hollingsworth, M. A., Swanson, B. J., Mucins in cancer: Protection and control of the cell surfacves. Nat. Rev. Cancer 2004, 4, 45-60.
2. Lehmann, J. M., Riethmuller, G., Johnson, J. P., MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc. Natl. Acad. Sci. USA 1989, 86, 9891-9895.
3. Chen, Y., Zhao, Y. H., Kalaslavadi, T. B., Hamati, E. et al., Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am. J. Respir. Cell Mol. Biol. 2004, 30, 155-165.
4. Higuchi, T., Orita, T., Nakanishi, S., katsuya, K. et al., Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J. Biol. Chem. 2004, 279, 1968-1979.
5. Moniaux, N., Escande, F., Porchet, N., Aubert, J. P., Batra, S. K., Structural organization and classification of the human mucin genes. Front. Biosci. 2001, 6, D1192-D1206.
6. Osako, M., Yonezawa, S., Siddiki, B., Huang, J. et al., Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 1993, 71, 2191-2199.
7. Yamashita, K., Yonezawa, S., Tanaka, S., Shirahama, H. et al., Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer 1993, 55, 82-91.
8. Kitamura, H., Yonezawa, S., Tanaka, S., Kim, Y. S., Sato, E., Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: Their relationship to prognosis. Jpn. J. Cancer Res. 1996, 87, 631-640.
9. Yonezawa, S., Sueyoshi, K., Nomoto, M., Kitamura, H. et al., MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients. Hum. Pathol. 1997, 28, 344-352.
10. Yonezawa, S., Sato, E., Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol. Int. 1997, 47, 813-830.
11. Utsunomiya, T., Yonezawa, S., Sakamoto, H., Kitamura, H. et al., Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients. Clin. Cancer Res. 1998, 4, 2605-2614.
12. Higashi, M., Yonezawa, S., Ho, J. J., Tanaka, S. et al., Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 1999, 30, 1347-1355.
13. Yonezawa, S., Nakamura, A., Horinouchi, M., Sato, E., The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. J. Hepatobiliary Pancreat. Surg. 2002, 9, 328-341.
14. Nakamura, A., Horinouchi, M., Goto, M., Nagata, K. et al., New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J. Pathol. 2002, 197, 201-210.
15. Tamada, S., Goto, M., Nomoto, M., Nagata, K. et al., Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis. Pathol. Int. 2002, 52, 713-723.
16. Carraway, K. L., Ramsauer, V. P., Haq, B., Carothers Carraway, C. A., Cell signaling through membrane mucins. Bioessays 2003, 25, 66-71.
17. Shibahara, H., Tamada, S., Higashi, M., Goto, M. et al., MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004, 39, 220-229.
18. Saitou, M., Goto, M., Horinouchi, M., Tamada, S. et al., MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J. Clin. Pathol. 2005, 58, 845-852.
19. Tamada, S., Shibahara, H., Higashi, M., Goto, M. et al., MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin. Cancer Res. 2006, 12, 4257-4264.
20. Tsutsumida, H., Goto, M., Kitajima, S., Kubota, I. et al., MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 2007, 55, 195-203.
21. Horinouchi, M., Nagata, K., Nakamura, A., Goto, M. et al., Expression of different glycoforms of membrane mucin (MUC1) and secretory mucin (MUC2, MUC5AC and MUC6) in pancreatic neoplasms. Acta Histochem. Cytochem. 2003, 36, 443-453.
22. Li, A., Goto, M., Horinouchi, M., Tanaka, S. et al., Expression of MUC1 and MUC2 mucins and relationship with cell proliferative activity in human colorectal neoplasia. Pathol. Int. 2001, 51, 853-860.
23. Gum, J. R., Jr., Hicks, J. W., Toribara, N. W., Siddiki, B., Kim, Y. S., Molecular cloning of human intestinal mucin (MUC2) cDNA: Identification of the amino terminus and overall sequence similarity to preprovon Willebrand factor. J. Biol. Chem. 1994, 269, 2440-2446.
24. Ohhashi, K., Takagi, K., ERCP and imaging diagnosis of pancreatic cancer. Gastroenterol. Endosc. 1980, 22, 1493-1495.
25. Sessa, F., Solcia, E., Capella, C., Bonato, M. et al., Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Archiv. 1994, 425, 357-367.
26. Yonezawa, S., Application of immunohistochemistry for diagnosis of neoplasms: Mucin antigens expression and biological behavior. Acta Histochem. Cytochem. 1994, 27, 561-566.
27. Yonezawa, S., Horinouchi, M., Osako, M., Kubo, M. et al., Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: Its relationship with the biological behavior of the tumors. Pathol. Int. 1999, 49, 45-54.
28. Furukawa, T., Klöppel, G., Adsay, N. V., Saavedra, J. A. et al., Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch. 2005, 447, 794-799.
29. Yonezawa, S., Taira, M., Osako, M., Kubo, M. et al., MUC1 mucin expression in invasive areas of intraductal papillary mucinous tumors of the pancreas. Pathol. Int. 1998, 48, 319-322.
30. Shibahara, H., Tamada, S., Goto, M., Oda, K. et al., Pathologic features of mucin-producing bile duct tumors: Two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am. J. Surg. Pathol. 2004, 28, 327-338.
31. Sagara, M., Yonezawa, S., Nagata, K., Tezuka, Y. et al., Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: Its relationship with prognosis. Int. J. Cancer 1999, 84, 251-257.
32. Matsukita, S., Nomoto, M., Kitajima, S., Tanaka, S. et al., Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: Comparison with invasive ductal carcinoma. Histopathology 2003, 42, 26-36.
33. Tsutsumida, H., Goto, M., Kitajima, S., Kubota, I. et al., Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small-size lung adenocarcinoma. Histopathology 2004, 44, 147-155.
34. Andrianifahanana, M., Moniaux, N., Schmied, B. M., Ringel, J. et al., Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: A potential role of MUC4 as a tumor marker of diagnostic significance. Clin. Cancer Res. 2001, 7, 4033-4040.
35. Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A. et al., MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol. 2002, 117, 791-796.
36. Balague, C., Gambus, G., Carrato, C., Porchet, N. et al., Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 1994, 106, 1054-1061.
37. Balague, C., Audie, J. P., Porchet, N., Real, F. X., In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 1995, 109, 953-964.
38. Vandenhaute, B., Buisine, M. P., Debailleul, V., Clement, B. et al., Mucin gene expression in biliary epithelial cells. J. Hepatol. 1997, 27, 1057-1066.
39. Ligtenberg, M. J., Buijs, F., Vos, H. L., Hilkens, J., Suppression of cellular aggregation by high level of episialin. Cancer Res. 1992, 52, 2318-2324.
40. Makiguchi, Y., Hinoda, Y., Imai, K., Effect of MUC1 mucin, and anti-adhesion molecule, on tumor cell growth. Jpn. J. Cancer Res. 1996, 87, 505-511.
41. Kondo, K., Kohno, N., Yokoyama, A., Hiwada, K., Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res. 1998, 58, 2014-2019.
42. Wesseling, J., Van der Valk, S. W., Vos, H. L., Sonnenberg, A. et al., Episialin (MUC1) over-expression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol. 1995, 129, 255-265.
43. van de Wiel-van Kemenade, E., Ligtenberg, M. J. L., de Boer, A. J., Buijs, F. et al., Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol. 1993, 151, 767-776.
44. Wesseling, J., Van der Valk, S. W., Hikens, J., A mechanism for inhibition of E-cadherin mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell. 1996, 7, 565-577.
45. Suwa, T., Hinoda, Y., Makiguti, Y., Increased invasiveness of MUC1 cDNA-transfected human gastric cancer MKN74 cells. Int. J. Cancer 1998, 76, 377-382.
46. Kohlgraf, K. G., Gawron, A. J., Higashi, M., Meza, J. L. et al., Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res. 2003, 63, 5011-5020.
47. Hattrup, C. L., Gendler, S. J., MUC1 alters oncogenic events and transcrption in human breast cancer cells. Breast Cancer Res. 2006, 8, R37.
48. Wei, X., Xu, H., Kufe, D., Human mucin 1 oncoprotein represses transcription of the p53 tumor supressor gene. Cancer Res. 2007, 67, 1853-1858.
49. Toribara, N. W., Gum, J. R., Culhane, P. J., Lagace, R. E. et al., MUC-2 human small intestinal mucin gene structure: Repeated arrays and polymorphism. J. Clin. Invest. 1991, 88, 1005-1013.
50. Carraway, K. L., Fregien, N., Mucin structure and function: Insights from molecular biology. Glycosci. Glycotechnol. 1995, 33, 31-44.
51. Porchet, N., Nguyen, V. C., Dufosse, J., Audie, J. P. et al., Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun. 1991, 175, 414-422.
52. Audie, J. P., Janin, A., Porchet, N., Copin, M. C. et al., Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J. Histochem. Cytochem. 1993, 41, 1479-1485.
53. Audie, J. P., Tetaert, D., Pigny, P., Buisine, M. P. et al., Mucin gene expression in the human endocervix. Hum. Reprod. 1995, 10, 98-102.
54. Gipson, I. K., Spurr-Michaud, S., Moccia, R., Zhan, Q. et al., MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol. Reprod. 1999, 60, 58-64.
55. Buisine, M. P., Devisme, L., Copin, M. C., Durand-Reville, M. et al., Developmental mucin gene expression in the human respiratory tract. Am. J. Respir. Cell Mol. Biol. 1999, 20, 209-218.
56. Moniaux, N., Nollet, S., Porchet, N., Degand, P. et al., Complete sequence of the human mucin MUC4: A putative cell membrane-associated mucin. Biochem. J. 1999, 338, 325-333.
57. Carraway, K. L., III, Rossi, E. A., Komatsu, M., Price-Schiavi, S. A. et al., An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol. Chem. 1999, 274, 5263-5266.
58. Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J. et al., The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (London) 1984, 312, 513-516.
59. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K. et al., Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 1986, 319, 230-234.
60. Jepson, S., Komatsu, M., Haq, B., Arango, M. E. et al., Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 2002, 21, 7524-7532.
61. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J. et al., p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8, 9-22.
62. Velcich, A., Yang, W., Heyer, J., Fragale, A. et al., Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002, 295, 1726-1729.
63. Jany, B. H., Gallup, M. W., Yan, P. S., Gallup, J. R. et al., Human bronchus and intestine express the same mucin gene. J. Clin. Invest. 1991, 87, 77-82.
64. Ho, J. J., Han, S. W., Pan, P. L., Deng, G. et al., Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. Int. J. Oncol. 2003, 22, 273-279.
65. Hanski, C., Riede, E., Gratchev, A., Foss, H. D. et al., MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation. Lab. Invest. 1997, 77, 685-695.
66. Riede, E., Gratchev, A., Foss, H. D., Mann, B. et al., Increased methylation of promotor region suppresses expression of MUC2 gene in colon carcinoma cells. Langenbecks Arch. Chir. Suppl. Kongressbd. 1998, 115, 299-302.
67. Gratchev, A., Siedow, A., Bumke-Vogt, C., Hummel, M. et al., Regulation of the intestinal mucin MUC2 gene expression in vivo: Evidence for the role of promoter methylation. Cancer Lett. 2001, 168, 71-80.
68. Hamada, T., Goto, M., Tsutsumida, H., Nomoto, M. et al., Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing. Cancer Lett. 2005, 227, 175-184.
69. Yamada, N., Hamada, T., Goto, M., Tsutsumida, H. et al., MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int. J. Cancer 2006, 119, 1850-1857.